Speakers

Speakers

Keynote Speakers

Arnon Afek
Associate Director General, Sheba Medical Center, Acting Chief Physician, Israeli Medical Cannabis Agency, Ministry of Health, Israel

Arnon Afek
Associate Director General, Sheba Medical Center, Acting Chief Physician, Israeli Medical Cannabis Agency, Ministry of Health, Israel
Ehud Barak
Chairman, Canndoc, Former Prime Minister, Israel

Click here for more information
Ehud Barak
Chairman, Canndoc, Former Prime Minister, Israel
Nadav Gil
Partner, Cannabis Tech Leader,Global Investment and Innovation Incentives, Deloitte Israel

Short Bio - click here
Nadav Gil
Partner, Cannabis Tech Leader,Global Investment and Innovation Incentives, Deloitte Israel
Philippe Lucas
VP, Global Patient Research & Access, Tilray Social Dimensions of Health, University of Victoria Graduate Researcher, Canadian Institute for Substance Use Research, Canada

Short Bio - click here
Philippe Lucas
VP, Global Patient Research & Access, Tilray Social Dimensions of Health, University of Victoria Graduate Researcher, Canadian Institute for Substance Use Research, Canada
Rishi Malkani
Partner, M&A Advisory, Transaction Services Cannabis practice Leader, Deloitte LLP., Canada

Short bio - click here
Rishi Malkani
Partner, M&A Advisory, Transaction Services Cannabis practice Leader, Deloitte LLP., Canada
Raphael Mechoulam
Prof., Institute for Drug Research, The Hebrew University of Jerusalem, Israel

Raphael Mechoulam
Prof., Institute for Drug Research, The Hebrew University of Jerusalem, Israel
Jonathan Page
PhD, Chief Science Officer, Aurora Cannabis Inc., Canada

Jonathan Page
PhD, Chief Science Officer, Aurora Cannabis Inc., Canada
Kevin Roland
Director, CMC Canopy Health Innovation, Canopy Growth Corporation, Canada

Kevin Roland
Director, CMC Canopy Health Innovation, Canopy Growth Corporation, Canada

Invited Speakers

Osnat Almogi-Hazan
Ph. D, Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel

Osnat Almogi-Hazan
Ph. D, Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel
Adi Aran
M.D., Director of the Neuro-pediatric unit, Shaare Zedek Medical Center, Jerusalem, Israel

Adi Aran
M.D., Director of the Neuro-pediatric unit, Shaare Zedek Medical Center, Jerusalem, Israel
Uri Ariel
Minister of Agriculture and Rural Development, Israel

Uri Ariel
Minister of Agriculture and Rural Development, Israel
Tal Ben David
Head Pharmacist, GreenPharma, Israel

Tal Ben David
Head Pharmacist, GreenPharma, Israel
Simon Benita
Prof. Emeritus, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University of Jerusalem, Israel

Short Bio - click here
Simon Benita
Prof. Emeritus, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University of Jerusalem, Israel
Ofra Benny
Head, Lab of Nanomedicine and Tumor Microenvironment, Multidisciplinary Center for Cannabinoid Research, The Hebrew University of Jerusalem, Israel

Click here for more information
Ofra Benny
Head, Lab of Nanomedicine and Tumor Microenvironment, Multidisciplinary Center for Cannabinoid Research, The Hebrew University of Jerusalem, Israel
David Berg
President & CTO, Strainprint

As President and Chief Technology Officer at Strainprint David is responsible for the ongoing development of the Strainprint application and emerging analytic products. David has a broad technical and business background with over 20 years of experience managing product and engineering teams for major multinational technology companies. David has spent the last 5 years working in the medical cannabis industry and has experience working in commercial cultivation and distribution in Holland, Jamaica and Canada. David has a BCom from York University and a Masters in Business Administration from the University of Windsor.

David Berg
President & CTO, Strainprint
Nirit Bernstein
Ph.D, Principle Research Scientist, Plant Physiology and Nutrition Institute of Soil Water and Environmental Sciences, Volcani Center, Israel

Short bio - click here
Nirit Bernstein
Ph.D, Principle Research Scientist, Plant Physiology and Nutrition Institute of Soil Water and Environmental Sciences, Volcani Center, Israel
Yossi Bornstein
Founder and Partner, Shizim Group and Cann10, Israel

Yossi Bornstein
Founder and Partner, Shizim Group and Cann10, Israel
David Casarett
MD MA; Chief of Palliative Care, Professor of Medicine, Duke University/Duke Health, USA

Short bio - click here
David Casarett
MD MA; Chief of Palliative Care, Professor of Medicine, Duke University/Duke Health, USA
Martin Chasen
Vice President Clinical Programs Medical Affairs, Tetra Bio-Pharma, Canada

Dr. Martin Chasen is currently the Medical Director of Palliative Care, at WOHS, (William Osler Health System)Brampton. He was previously Medical Director, Palliative Care, at The Ottawa Hospital Cancer Centre and the Palliative Rehabilitation Program at Élisabeth Bruyère Hospital, Ottawa. Born in Pretoria, South Africa, Dr. Chasen completed his undergraduate training in medicine and surgery at the University of Pretoria in 1983, later obtaining a specialist degree in Internal Medicine and Medical Oncology and Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa.

Martin Chasen
Vice President Clinical Programs Medical Affairs, Tetra Bio-Pharma, Canada
Abigail Dar
Founder of CannaFora, Israel

Founder & CEO – CannaFora – Cannabis for Autism Treatment and Research Center. An Autism Mother and Advocate, A board member of “Alut – the Israeli Society for children with Autism”. Leader of public awareness for Medical Cannabis for Autism in Israel and Worldwide. Initiator of breakthrough scientific academic research in the field of the use of MC by autistic children.
CannaFora Center treats hundreds of patients with Autism – in holistic approach to find the right product, dosing and delivery method along with Specializing Doctors in Autism and Medical Cannabis Therapies.

Abigail Dar
Founder of CannaFora, Israel
Elyad Davidson
Prof., Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel

Prof. Davidson is the Director of the pain relief unit in Hadassah Hebrew University Medical Center. He completed his anesthesiology residency in Hadassah Hebrew University Medical Center and earned higher education in pain practice and research in the University of Texas-Houston School of Medicine (2 years Herman hospital) and in the University of Miami School of Medicine (1 year Jackson Memorial). Prof. Davidson was a board member of the Israeli Pain Association and is the current president of IASP. He is involved in educating the medical community and public regarding pain management.

Elyad Davidson
Prof., Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel
Ruth Djaldetti
Prof. Movement Disorder Clinic, Department of Neurology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel

Prof. Djaldetti, M.D is an Associate Professor at the Sackler Faculty of Medicine at Tel Aviv University. Prof. Djaldetti was a research fellow at Columbia University, New York, between 1998-2000. Since then she serves as head of the Movement Disorder Clinic at Rabin Medical Center.

Ruth Djaldetti
Prof. Movement Disorder Clinic, Department of Neurology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel
Abraham J. Domb
Phd. Cannabinoids Research Multidisciplinary Center, Hebrew University of Jerusalem, Israel

Abraham J. Domb
Phd. Cannabinoids Research Multidisciplinary Center, Hebrew University of Jerusalem, Israel
Michael Dor
Dr. MD. MPA. Senior Medical Advisor Medical Cannabis Unit, Cannatech, Israel

Dr Michael Dor served as the Senior Medical Advisor of the Medical Cannabis Unit in the Israeli Ministry of Health for the last five years. He is a specialist in Family Medicine and in Health Management and earned his Master in Public Administration in Harvard University. Dr Dor was the Head of the Hospitals Division and Deputy Director of the Health Administration in Israel. His activities included establishing a volunteers clinic for uninsured refugees and medical treatment for women victims of human trafficking . For those activities he received the Presidential Award - the highest civilian honour in Israel.

Michael Dor
Dr. MD. MPA. Senior Medical Advisor Medical Cannabis Unit, Cannatech, Israel
Orna Dreazen
CEO & Chairperson of the board Nextar Chempharma Solutions Ltd.

Orna Dreazen
CEO & Chairperson of the board Nextar Chempharma Solutions Ltd.
Shiry Eden
CEO at Nishot Strategy and Analysis and advisor at 'Sela Cannabis' mutual fund, Israel

Short Bio - Click here
Shiry Eden
CEO at Nishot Strategy and Analysis and advisor at 'Sela Cannabis' mutual fund, Israel
Ziva Eger
Chief Executive of Foreign Investments & Industrial Co-operation, Israel

Experienced Chief Executive Officer with a demonstrated history of working in the government administration industry. Skilled in Entrepreneurship, Management, Strategic Planning, Strategy, and Business Strategy. Strong business development professional with a Master's degree focused in Economics from Tel Aviv University.

Ziva Eger
Chief Executive of Foreign Investments & Industrial Co-operation, Israel
Ianiv Eisenscher
Chief Product Officer, Syqe Medical, Israel

Ianiv Eisenscher
Chief Product Officer, Syqe Medical, Israel
Alla Falkovich
Bioanalytical R&D Manager and Study Director, Analyst Labs, Israel

Alla has two MSc degrees: one in engineering from Moscow and another in Chemistry from the Weizmann Institute of Science. She continued her graduate education and eventually she got Ph.D. in Chemistry from the Weizmann Institute of Science. Alla has 12 publications in leading chemical journals.
Alla worked as Chemist-analyst and Scientist-researcher in Bioanalytical R&D and Drug discovery for more than 20 years. Since 2009 she works at Analyst Laboratories as Bioanalytical R&D manager and Study director. She runs Bioanalytical LC-MS/MS laboratory.

Alla Falkovich
Bioanalytical R&D Manager and Study Director, Analyst Labs, Israel
Ofer Finkelstein
VP Sales, Juganu

Ofer Finkelstein
VP Sales, Juganu
Clifton Flack
Founder at CiiTECH, Israel

Born in the UK though living in Israel since 2005, Clifton has accumulated over 25 years consumer and corporate marketing experience. Entering the emerging medical cannabis industry in late 2014, Clifton helped create CannaTech, the International conference on Medical Cannabis innovation & investment. Seeing the regulatory challenges, in 2017 Clifton founded his second cannabis company CiiTECH, focusing on the food supplement regulated CBD industry in the UK.

Clifton Flack
Founder at CiiTECH, Israel
Ilan Gerzi
Senior Partner, Chair of the Capital Markets and Securities Group at Pearl Cohen, Israel

Ilan Gerzi
Senior Partner, Chair of the Capital Markets and Securities Group at Pearl Cohen, Israel
Miles Gilman
CEO, Sunhealth Therapeutics, USA

Miles Gilman
CEO, Sunhealth Therapeutics, USA
Liron Goldshtein
Head, Cannabis Pharmacy Dept, GreenPharma, Israel

Liron Goldshtein
Head, Cannabis Pharmacy Dept, GreenPharma, Israel
Amir Goldstein
Chief Operations Officer, IMC, Israel

Amir is seasoned executive in the Israeli Hi-Tech industry with over 30 years of experience. Amir served in various managerial position at Amdocs, the world leader in Telecom Billing & Customer Care software. Amir was also a founder and Executive Vice president at Cellcom LTD. (Israel’s leading Mobile Operator), Chairman and CEO of Todacell Inc. (an international mobile advertising company) and serves as Managing Partner of two private equity funds, Botticelli and Afterdox.

Amir Goldstein
Chief Operations Officer, IMC, Israel
Jonathan Grunfeld
MD, Palliative Care, Asaf Harofeh Medical Center, Israel

Jonathan Grunfeld, Graduated with M.D. in medicine from the Telv Aviv University in 1996, certified in neurology 2002, completed a fellowship in neuro-oncology in the M.D. Anderson Cancer Center in 2004. Primarily active in oncological symptom management in the Assaf HaRofeh Medical Center since 2005. First witnessed the medical benefits of cannabis directly circa 2009, and since then acquired authority to issue permits for medical use of cannabis in cancer patients and accumulated experience with over 4000 patients issued such permits.

Jonathan Grunfeld
MD, Palliative Care, Asaf Harofeh Medical Center, Israel
Lumir Hanuš
Chief Scientist, Asana Bio Group Ltd., Israel

Lumir Hanuš
Chief Scientist, Asana Bio Group Ltd., Israel
Elizabeth Hatchuel
Adjunct Professor, Universidade Federal Rural do Rio de Janeiro, Brazil

Graduated in Administration. MBA in Marketing and Master in Business Management, both from FGV. PhD in Science, Technology and Innovation in the Agricultural Business from Universidade Federal Rural do Rio de Janeiro (UFRRJ). Adjunct Professor of Social and Business Sciences at UFRRJ. Has international experience in strategic marketing in healthcare.

Elizabeth Hatchuel
Adjunct Professor, Universidade Federal Rural do Rio de Janeiro, Brazil
Steve Hawkins
President and CEO of Horizons ETFs, Canada

Short Bio - click here
Steve Hawkins
President and CEO of Horizons ETFs, Canada
Vered Hermush
Dr. Medical Director Geriatric Wing, Laniado Hospital, Israel

Short Bio - Click here
Vered Hermush
Dr. Medical Director Geriatric Wing, Laniado Hospital, Israel
Arnon Heyman
Phd, CEO Canonic, Israel

Short Bio - Click here
Arnon Heyman
Phd, CEO Canonic, Israel
Saul Kaye
Founder and CEO, iCANN, Israel

Short Bio - Click here
Saul Kaye
Founder and CEO, iCANN, Israel
Itzhak Kurek
PhD, CEO and co-founder of Cannformatics Inc, USA

Short Bio - Click here
Itzhak Kurek
PhD, CEO and co-founder of Cannformatics Inc, USA
Zohar Levy
Co-Founder, CEO, Chairman, Seedo, Israel

Zohar Levy
Co-Founder, CEO, Chairman, Seedo, Israel
Gilad Livni
Cannabis Consulted Breeder, Israel

Gilad Livni
Cannabis Consulted Breeder, Israel
David (Dedi) Meiri
Ph.D, Head of Scientific Advisory Board, Assistant Professor, Heads the ``Laboratory of Cancer Biology and Cannabinoid Research`` Technion, Institute of Technology, Israel

David (Dedi) Meiri
Ph.D, Head of Scientific Advisory Board, Assistant Professor, Heads the ``Laboratory of Cancer Biology and Cannabinoid Research`` Technion, Institute of Technology, Israel
Gal Meiri
M.D., Head of Preschool Psychiatric Unit, Soroka Medical Center, Clinical Director of the National Autism Research Center of Israel, Ben Gurion University of the Negev, Israel

Gal Meiri
M.D., Head of Preschool Psychiatric Unit, Soroka Medical Center, Clinical Director of the National Autism Research Center of Israel, Ben Gurion University of the Negev, Israel
Itai Melchior
Head of the Inter-Ministerial Committee for the Export of Medicinal Cannabis, Foreign Trade Administration, Ministry of Economy & Industry, Israel

Itai Melchior
Head of the Inter-Ministerial Committee for the Export of Medicinal Cannabis, Foreign Trade Administration, Ministry of Economy & Industry, Israel
Victor Novack
Prof., Head of Soroka Clinical Research Center, Israel

Short Bio - click here
Victor Novack
Prof., Head of Soroka Clinical Research Center, Israel
Reuven Or
M.D Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel

Reuven Or
M.D Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel
Hadile Ounallah-Saad
VP R&D, CannAssure, Israel

Hadile Ounallah-Saad
VP R&D, CannAssure, Israel
Avi Priel
Assoc. Prof., Head, Ion Channels Biophysics and Pharmacology Laboratory Chair, Pharmacology Section, The Multidisciplinary Center for Cannabinoid Research, Israel

Short Bio - click here
Avi Priel
Assoc. Prof., Head, Ion Channels Biophysics and Pharmacology Laboratory Chair, Pharmacology Section, The Multidisciplinary Center for Cannabinoid Research, Israel
Jeremy Riggle
Chief Scientist, Mary's Medicinals, USA

Dr. Jeremy Riggle is currently the Chief Scientist at Mary’s Medicinals, Mary’s Nutritionals, Mary’s Whole Pet, and Mary’s Methods located in Denver, CO. Mary’s is a leader in transdermal and topical delivery technology of phytocannabinoids for therapeutic applications, including the award winning transdermal patch and patented transdermal Gel Pen. He received his Ph.D. in Analytical Chemistry from the University of Idaho in Moscow, ID.

Jeremy Riggle
Chief Scientist, Mary's Medicinals, USA
Dror Robinson
Chairman, Israeli Association of Cannabis Medicine

Dror Robinson
Chairman, Israeli Association of Cannabis Medicine
Karina Rubinstein
Director of Business Development, Start Up Division at Israel Innovation Authority, Israel

Karina Rubinstein
Director of Business Development, Start Up Division at Israel Innovation Authority, Israel
Shay Avraham Sarid
Co-Founder & CTO, Seach Medical Cannabis Group, Israel

Shay Avraham Sarid
Co-Founder & CTO, Seach Medical Cannabis Group, Israel
Dadi Segal
CEO, Panaxia, Israel

Dadi Segal
CEO, Panaxia, Israel
Ariel Sender
Chief Business Director, Gilad Group, Israel

Click here for more information
Ariel Sender
Chief Business Director, Gilad Group, Israel
Pesach Shvartzman
Chairman, Division of Community Health, Head, Pain and Palliative Care Unit, Soroka Medical Center and Faculty of Health Sciences, Ben Gurion University, Chair, Israel Palliative Care Association, Israel

Click here for more information
Pesach Shvartzman
Chairman, Division of Community Health, Head, Pain and Palliative Care Unit, Soroka Medical Center and Faculty of Health Sciences, Ben Gurion University, Chair, Israel Palliative Care Association, Israel
Gurmit Singh
Professor, Pathology and Molecular Medicine, Singh laboratory, McMaster University, Canada

Dr. Gurmit Singh is a Professor of Pathology and Molecular Medicine at McMaster University and a Senior Scientist at Hamilton Health Sciences. He serves on a number of national and international scientific review panels. He has published over 200 papers and edited 4 books. His current interest is in “Oncodynamics” – namely effect of cancer cells on the body. He is specifically interested in neuropathic pain with emphasis on sex differences. He is currently studying the role of cannabis in pain management using preclinical models.

Gurmit Singh
Professor, Pathology and Molecular Medicine, Singh laboratory, McMaster University, Canada
Brenda Smith
MBA, CFP®, Founder, Managing Partner, CB Capital Concierge, Chair, Tiger 21, Board, America-Israel Cannabis Association, USA

Click here for more information
Brenda Smith
MBA, CFP®, Founder, Managing Partner, CB Capital Concierge, Chair, Tiger 21, Board, America-Israel Cannabis Association, USA
Orit Stolar
M.D., Pediatric Neurologist, Assaf Harofeh Medical Center, Israel

Orit Stolar
M.D., Pediatric Neurologist, Assaf Harofeh Medical Center, Israel
Yossi (Joseph) Tam
M.D., Ph.D., Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine ,Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel

Yossi (Joseph) Tam
M.D., Ph.D., Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine ,Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
Avihu Tamir
Founder & CEO, Kanabo Research, Israel

Avihu Tamir is a cannabis entrepreneur with over five years of hands-on experience in multiple Israeli medical cannabis ventures. He is the Founder and CEO of Kanabo Research, a medical cannabis R&D company based in Tel Aviv that focuses on building IP for inhaling medical cannabis, through vaporizer technology platforms and applications of patented cannabis formulations. Before starting Kanabo Research, Avihu was the founder of Teva Nature, the leading vaporizer company in Israel, and worked as a senior strategy consultant at Accenture.

Avihu Tamir
Founder & CEO, Kanabo Research, Israel
Narkis Tessler
CEO, TeraCann, Israel

Click here for more information
Narkis Tessler
CEO, TeraCann, Israel
Boaz Wachtel
Chairman, Creso Pharma, Israel

Short Bio - Click here
Boaz Wachtel
Chairman, Creso Pharma, Israel
Hagit Weinstock
ADV, Partner in Weinstock-Zehavi Law Offices, Israel

Short Bio - Click here
Hagit Weinstock
ADV, Partner in Weinstock-Zehavi Law Offices, Israel
Ma'ayan Weisberg Joels
Business Development Manager, Tikun Olam, Israel

Ma'ayan Weisberg Joels
Business Development Manager, Tikun Olam, Israel
Rami Yaka
Prof., Head, Lab of Addiction Neuroscience, Dr. Leon Deutsch and Dr. Mina Deutsch Chair in Psychopharmacology, The Hebrew University of Jerusalem, Israel

Short Bio - click here
Rami Yaka
Prof., Head, Lab of Addiction Neuroscience, Dr. Leon Deutsch and Dr. Mina Deutsch Chair in Psychopharmacology, The Hebrew University of Jerusalem, Israel
Andreas Zimmer
Prof., Director, Institute of Molecular Psychiatry University of Bonn, Germany

Short Bio - click here
Andreas Zimmer
Prof., Director, Institute of Molecular Psychiatry University of Bonn, Germany
Yuval (Tuby) Zolotov
Ph.D, Network and Partnership Coordinator, International Association for Cannabinoid Medicine, Israel

Yuval (Tuby) Zolotov
Ph.D, Network and Partnership Coordinator, International Association for Cannabinoid Medicine, Israel
Print Friendly, PDF & Email